201 related articles for article (PubMed ID: 29576497)
1. Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors.
Zhang C; Leng W; Sun C; Lu T; Chen Z; Men X; Wang Y; Wang G; Zhen B; Qin J
EBioMedicine; 2018 Apr; 30():120-128. PubMed ID: 29576497
[TBL] [Abstract][Full Text] [Related]
2. Urinary protein biomarker panel predicts esophageal squamous carcinoma from control cases and other tumors.
Ji L; Wang J; Yang B; Zhu J; Wang Y; Jiao J; Zhu K; Zhang M; Zhai L; Gong T; Sun C; Qin J; Wang G
Esophagus; 2022 Oct; 19(4):604-616. PubMed ID: 35792948
[TBL] [Abstract][Full Text] [Related]
3. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
[TBL] [Abstract][Full Text] [Related]
4. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
[TBL] [Abstract][Full Text] [Related]
5. Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics.
López-Sánchez LM; Jurado-Gámez B; Feu-Collado N; Valverde A; Cañas A; Fernández-Rueda JL; Aranda E; Rodríguez-Ariza A
Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L664-L676. PubMed ID: 28619761
[TBL] [Abstract][Full Text] [Related]
6. Using feature selection and Bayesian network identify cancer subtypes based on proteomic data.
Wang Y; Gao X; Ru X; Sun P; Wang J
J Proteomics; 2023 May; 280():104895. PubMed ID: 37024076
[TBL] [Abstract][Full Text] [Related]
7. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
Zang R; Wang X; Jin R; Lei Y; Huang J; Liu C; Zheng S; Zhou F; Wu Q; Sun N; Gao S; He J
J Transl Med; 2019 Dec; 17(1):430. PubMed ID: 31888670
[TBL] [Abstract][Full Text] [Related]
8. Proteomic biomarkers for lung cancer progression.
Ren Y; Zhao S; Jiang D; Feng X; Zhang Y; Wei Z; Wang Z; Zhang W; Zhou QF; Li Y; Hou H; Xu Y; Zhou F
Biomark Med; 2018 Mar; 12(3):205-215. PubMed ID: 29424557
[TBL] [Abstract][Full Text] [Related]
9. Urinary protein biomarkers in the early detection of lung cancer.
Nolen BM; Lomakin A; Marrangoni A; Velikokhatnaya L; Prosser D; Lokshin AE
Cancer Prev Res (Phila); 2015 Feb; 8(2):111-9. PubMed ID: 25416410
[TBL] [Abstract][Full Text] [Related]
10. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J
J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301
[TBL] [Abstract][Full Text] [Related]
11. Serum mass profile signature as a biomarker of early lung cancer.
Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
[TBL] [Abstract][Full Text] [Related]
12. Urinary protein biomarkers for pediatric medulloblastoma.
Hao X; Guo Z; Sun H; Liu X; Zhang Y; Zhang L; Sun W; Tian Y
J Proteomics; 2020 Aug; 225():103832. PubMed ID: 32474013
[TBL] [Abstract][Full Text] [Related]
13. The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
Nielsen HH; Beck HC; Kristensen LP; Burton M; Csepany T; Simo M; Dioszeghy P; Sejbaek T; Grebing M; Heegaard NH; Illes Z
PLoS One; 2015; 10(10):e0139659. PubMed ID: 26460890
[TBL] [Abstract][Full Text] [Related]
14. Comparative Proteomic Analysis of Exosomes and Microvesicles in Human Saliva for Lung Cancer.
Sun Y; Huo C; Qiao Z; Shang Z; Uzzaman A; Liu S; Jiang X; Fan LY; Ji L; Guan X; Cao CX; Xiao H
J Proteome Res; 2018 Mar; 17(3):1101-1107. PubMed ID: 29397740
[TBL] [Abstract][Full Text] [Related]
15. Early urinary protein changes during tumor formation in a NuTu-19 tail vein injection rat model.
Wei J; Ni N; Meng W; Huan Y; Gao Y
Sci Rep; 2020 Jul; 10(1):11709. PubMed ID: 32678190
[TBL] [Abstract][Full Text] [Related]
16. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
Shinke H; Masuda S; Togashi Y; Ikemi Y; Ozawa A; Sato T; Kim YH; Mishima M; Ichimura T; Bonventre JV; Matsubara K
Cancer Chemother Pharmacol; 2015 Nov; 76(5):989-96. PubMed ID: 26407820
[TBL] [Abstract][Full Text] [Related]
17. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
18. Serum proteomics profiling identifies a preliminary signature for the diagnosis of early-stage lung cancer.
Gasparri R; Noberini R; Cuomo A; Yadav A; Tricarico D; Salvetto C; Maisonneuve P; Caminiti V; Sedda G; Sabalic A; Bonaldi T; Spaggiari L
Proteomics Clin Appl; 2023 Mar; 17(2):e2200093. PubMed ID: 36645712
[TBL] [Abstract][Full Text] [Related]
19. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
20. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]